Transforming growth factor beta receptor type I (TGF-βRI) kinase inhibitors IOA-359 and IOA-360 stimulate erythropoiesis in MDS.

Autor: Ramachandra, Nandini¹ (AUTHOR), Vegivinti, Charan Thej Reddy¹ (AUTHOR), Sahu, Srabani¹ (AUTHOR), Sanawar, Rahul¹ (AUTHOR), Rivera-Peña, Bianca¹ (AUTHOR), Aminov, Sarah¹ (AUTHOR), Fromowitz, Ariel¹ (AUTHOR), Zhang, Jinghang¹ (AUTHOR), Aodengtuya, Fnu¹ (AUTHOR), Pradhan, Kith¹ (AUTHOR), Zhao, Rongbao¹ (AUTHOR), Schwartz, Leya¹ (AUTHOR), Alluri, Srinivas¹ (AUTHOR), Thiruvananthapuram, Victor¹ (AUTHOR), Rabinovich, Emma¹ (AUTHOR), Ajibade, Opeyemi¹ (AUTHOR), Gordon-Mitchell, Shanisha¹ (AUTHOR), Shastri, Aditi¹ (AUTHOR), Deken, Marcel² (AUTHOR), Yingling, Jonathan M.^3,4 (AUTHOR)

Publikováno v: Leukemia & Lymphoma. Dec2024, p1-10. 10p. 6 Illustrations.